This legislation is designed to significantly expand and sustain the national investment in biomedical research. It authorizes and directly appropriates substantial funding for several key federal agencies involved in health and medical research. These agencies include the National Institutes of Health (NIH) , the Centers for Disease Control and Prevention (CDC) , the Department of Defense's research, development, test, and evaluation program for health, and the Department of Veterans Affairs' medical and prosthetics research program. The bill specifies increasing appropriation amounts for each of these entities annually, beginning in fiscal year 2027 and extending through fiscal year 2036. For fiscal year 2037 and all subsequent years, the funding will be adjusted upwards based on the percentage increase in the Consumer Price Index for all urban consumers, ensuring that the investment keeps pace with inflation. All appropriated funds are designated to remain available until expended, providing flexibility for long-term research projects. A critical provision of this Act is the protection of these appropriations from potential budget cuts. The bill explicitly amends existing law to exempt this funding from sequestration orders . Furthermore, the budgetary effects of this section are not to be entered on either statutory or Senate PAYGO scorecards , thereby safeguarding this expanded investment in biomedical research from future fiscal constraints.